Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
|
|
23 April 2025
| Name: | CANNPAL ANIMAL THERAPEUTICS LIMITED (CP1) |
| ISIN: | AU000000CP17 |
| Date of Listing: | 25 October 2017 |
| Date of Delisting: | 18 March 2021 |
Stock Exchange Status:
This entity was delisted from the Australian Securities Exchange on 18 March 2021.Legal Status:
ACN: 612 791 518ABN: 88 612 791 518
Registration Date: 03 June 2016
Capital Gains Tax (CGT) Status:
To our knowledge this entity was the subject of a takeover or merger such that your securities were acquired for consideration in the form of cash or scrip. You will need to seek independent tax advice in relation to Capital Gains Tax or other tax matters but any other enquiries relating to your shareholding in the company should be followed up via our online form here: https://www.delisted.com.au/TraceLostSharesLostMoney/index/.
Updates, corrections, disagreements please email to admin@delisted.com.au
Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.
Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.
Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.
REGISTRY:
Computershare Brisbane
Level 1, 200 Mary Street Brisbane QLD 4000
Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 7 3229 9860
RegistryWebsite RegistryEmail
delisted from the close of trading on Thursday, 18 March 2021, pursuant to Listing rule 17.11. | 18/03/2021 |
we understand AusCann Group Holdings Limited acquired all of the issued shares in CP1 and issued 1.3 fully paid ordinary shares in AusCann for every CannPal share held as at the Scheme record date being 7pm (AEDT) on 15 March 2021 | 18/03/2021 |
Eligible former CannPal shareholders have been issued 1.3 fully paid ordinary shares in AusCann for every CannPal share they held as at the Scheme record date being 7pm (AEDT) on 15 March 2021. AusCann has issued a total of 123,499,753 new ordinary shares in AusCann to former CannPal shareholders as consideration for the transfer of their CannPal shares to AusCann. Eligible former CannPal shareholders will be sent holding statements recording the number of new AusCann shares issued to the holder under the Scheme. | 18/03/2021 |
CannPal Animal Therapeutics Limited today implemented its scheme of arrangement under which CannPal shareholders received 1.3 new fully paid ordinary shares in AusCann for every 1 fully paid ordinary share held in CannPal at 7.00pm (AEDT) on 15 March 2021. All fully paid ordinary shares in CannPal were transferred to AusCann and CannPal is now a wholly owned subsidiary of AusCann and will be removed from the official list of the ASX shortly. | 18/03/2021 |
The securities of CannPal Animal Therapeutics Limited will be suspended from quotation at the close of trading today, Thursday, 11 March 2021, in accordance with Listing Rule 17.2, following lodgement of the Supreme Court of Western Australia's orders with the Australian Securities and Investments Commission approving the scheme of arrangement by which AusCann Group Holdings Limited will acquire all of the issued shares in CP1. | 11/03/2021 |
listed entity carried for record purposes only | 25/10/2017 |
delisted from the close of trading on Thursday, 18 March 2021, pursuant to Listing rule 17.11. | 18/03/2021 |
we understand AusCann Group Holdings Limited acquired all of the issued shares in CP1 and issued 1.3 fully paid ordinary shares in AusCann for every CannPal share held as at the Scheme record date being 7pm (AEDT) on 15 March 2021 | 18/03/2021 |
Eligible former CannPal shareholders have been issued 1.3 fully paid ordinary shares in AusCann for every CannPal share they held as at the Scheme record date being 7pm (AEDT) on 15 March 2021. AusCann has issued a total of 123,499,753 new ordinary shares in AusCann to former CannPal shareholders as consideration for the transfer of their CannPal shares to AusCann. Eligible former CannPal shareholders will be sent holding statements recording the number of new AusCann shares issued to the holder under the Scheme. | 18/03/2021 |
CannPal Animal Therapeutics Limited today implemented its scheme of arrangement under which CannPal shareholders received 1.3 new fully paid ordinary shares in AusCann for every 1 fully paid ordinary share held in CannPal at 7.00pm (AEDT) on 15 March 2021. All fully paid ordinary shares in CannPal were transferred to AusCann and CannPal is now a wholly owned subsidiary of AusCann and will be removed from the official list of the ASX shortly. | 18/03/2021 |
The securities of CannPal Animal Therapeutics Limited will be suspended from quotation at the close of trading today, Thursday, 11 March 2021, in accordance with Listing Rule 17.2, following lodgement of the Supreme Court of Western Australia's orders with the Australian Securities and Investments Commission approving the scheme of arrangement by which AusCann Group Holdings Limited will acquire all of the issued shares in CP1. | 11/03/2021 |
listed entity carried for record purposes only | 25/10/2017 |
Your browser may reflect a date of printing in American format.
Purchases Sales
| DATE | DIRECTOR | NATURE | NUMBER | PRICE | AMOUNT |
|---|---|---|---|---|---|
| 09/12/2019 | Layton Mills | 38,337 | $0.115 | $4,409 | |
| 09/12/2019 | Layton Mills | 44,000 | $0.115 | $5,060 | |
| 05/12/2019 | Layton Mills | 47,663 | $0.119 | $5,691 | |
| 21/11/2019 | Geoff Starr | 120,000 | $0.123 | $14,798 | |
| 24/05/2019 | Layton Mills | 104,500 | $0.145 | $15,153 |
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Geoff Starr | Chairman | 23/04/2017 |
| Layton Mills | Managing Director, CEO | 05/06/2017 |
| Baden Bowen | CFO, Company Secretary | 25/10/2017 |
| Rob Clifford | Non Exec Director | 03/02/2017 |
| Kate Adams | Non Exec Director | 23/04/2017 |
Date of first appointment, title may have changed.
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|---|---|---|
| Max Johnston | Non Exec Director | 25/10/2017 | 03/09/2020 |
Date of first appointment, title may have changed.
Contact Us | Financial Services Guide | Privacy Policy
This website is owned and operated by Investogain Pty Limited.
ABN 88 129 443 447 | AFSL 334036
Information provided is of a general nature and not for trading or advice.
Copyright © 2002-2025 Investogain Pty Limited. All rights reserved.
